2018年
Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy.
Proceedings of the Japan Academy. Series B, Physical and biological sciences
- ,
- ,
- ,
- ,
- ,
- 巻
- 94
- 号
- 3
- 開始ページ
- 153
- 終了ページ
- 160
- DOI
- 10.2183/pjab.94.011
- ID情報
-
- DOI : 10.2183/pjab.94.011
- ISSN : 0386-2208
- PubMed ID : 29526974